Home › Funds › Artisan Partners Limited Partnership › ASND
Artisan Partners Limited Partnership position in ASND
ASCENDIS PHARMA A/S · Health Care
Artisan Partners Limited Partnership reported holding 2,083,019 shares of ASND (ASCENDIS PHARMA A/S) in its Q3 2026 13F filing — a position valued at US$474.6M, representing 0.88% of its reported portfolio and ranking #30 among its reported holdings. Artisan Partners Limited Partnership has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Artisan Partners Limited Partnership's ASND position evolved
Artisan Partners Limited Partnership first disclosed a stake in ASND in Q3 2023 at 5,995,408 shares (US$561.4M). The position peaked in Q1 2024 at 5,671,934 shares, worth US$857.4M. Across 13 filings, Artisan Partners Limited Partnership increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,083,019 shares valued at US$474.6M — a reduction of -551,005 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.00M | $561.41M | New |
| Q4 2023 | 5.75M | $724.12M | Reduce |
| Q1 2024 | 5.67M | $857.43M | Reduce |
| Q2 2024 | 4.30M | $585.76M | Reduce |
| Q3 2024 | 4.41M | $658.62M | Add |
| Q4 2024 | 4.45M | $612.69M | Add |
| Q1 2025 | 4.26M | $663.44M | Reduce |
| Q2 2025 | 3.99M | $688.75M | Reduce |
| Q3 2025 | 3.72M | $739.75M | Reduce |
| Q4 2025 | 3.23M | $687.89M | Reduce |
| Q1 2026 | 3.23M | $738.84M | Hold |
| Q2 2026 | 2.63M | $702.55M | Reduce |
| Q3 2026 | 2.08M | $474.58M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ASND and 13F data
ASND (ASCENDIS PHARMA A/S) is a Health Care company. 36 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ASND
- RA CAPITAL MANAGEMENT, L.P. 10.28M sh · $2.74B · Q2 2026
- T. Rowe Price Investment Management, Inc. 6.75M sh · $1.80B · Q2 2026
- Avoro Capital Advisors LLC 5.11M sh · $1.36B · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 5.13M sh · $1.17B · Q3 2026
- Jupiter Topco LLC 3.65M sh · $973.38M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.16M sh · $310.39M · Q2 2026
- Vestal Point Capital, LP 375.00K sh · $100.02M · Q2 2026
- Tri Locum Partners LP 258.74K sh · $69.01M · Q2 2026
- ORBIMED ADVISORS LLC 244.46K sh · $65.20M · Q2 2026
- PFM Health Sciences, LP 233.17K sh · $62.19M · Q2 2026
- Frazier Life Sciences Management, L.P. 225.16K sh · $60.05M · Q2 2026
More on Artisan Partners Limited Partnership
FAQ
How long has Artisan Partners Limited Partnership held ASND?
Artisan Partners Limited Partnership has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Artisan Partners Limited Partnership's current position in ASND?
As of Q3 2026, Artisan Partners Limited Partnership holds 2.08M shares of ASND (ASCENDIS PHARMA A/S), valued at $474.58M, representing 0.88% of its reported portfolio and ranking #30.
Has Artisan Partners Limited Partnership been buying or selling ASND?
In the latest 13F filing (Q3 2026), Artisan Partners Limited Partnership reduced its position in ASND. The position peaked in Q1 2024 at 5.67M shares.
Which other funds hold ASND?
Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.